Bruker Co. (NASDAQ:BRKR) Shares Bought by Lane Generational LLC

Lane Generational LLC boosted its position in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 228.4% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 66,552 shares of the medical research company's stock after acquiring an additional 46,284 shares during the period. Bruker comprises 3.8% of Lane Generational LLC's investment portfolio, making the stock its 14th biggest holding. Lane Generational LLC's holdings in Bruker were worth $3,901,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in BRKR. Wealth Enhancement Advisory Services LLC lifted its position in shares of Bruker by 1.4% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 13,287 shares of the medical research company's stock worth $779,000 after buying an additional 177 shares during the last quarter. Arizona State Retirement System lifted its position in shares of Bruker by 0.7% during the 4th quarter. Arizona State Retirement System now owns 30,725 shares of the medical research company's stock worth $1,801,000 after buying an additional 222 shares during the last quarter. CIBC Asset Management Inc lifted its position in shares of Bruker by 5.6% during the 4th quarter. CIBC Asset Management Inc now owns 4,233 shares of the medical research company's stock worth $248,000 after buying an additional 223 shares during the last quarter. UMB Bank n.a. lifted its position in shares of Bruker by 37.5% during the 4th quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock worth $53,000 after buying an additional 248 shares during the last quarter. Finally, Blue Trust Inc. lifted its position in shares of Bruker by 13.5% during the 4th quarter. Blue Trust Inc. now owns 2,164 shares of the medical research company's stock worth $127,000 after buying an additional 257 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. The Goldman Sachs Group upgraded shares of Bruker from a "sell" rating to a "neutral" rating and set a $60.00 price objective for the company in a research report on Thursday, December 5th. Bank of America upped their price target on shares of Bruker from $78.00 to $80.00 and gave the company a "buy" rating in a research report on Friday, December 13th. UBS Group initiated coverage on shares of Bruker in a research report on Tuesday, December 10th. They issued a "neutral" rating and a $66.00 price target for the company. Barclays reduced their price target on shares of Bruker from $69.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Finally, Guggenheim reissued a "buy" rating on shares of Bruker in a research note on Monday, February 24th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, Bruker has a consensus rating of "Moderate Buy" and an average target price of $70.50.

Remove Ads

Bruker Stock Performance

NASDAQ:BRKR opened at $45.56 on Wednesday. The stock has a market cap of $6.91 billion, a PE ratio of 59.95, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. Bruker Co. has a fifty-two week low of $44.89 and a fifty-two week high of $94.86. The firm's fifty day simple moving average is $54.48 and its 200-day simple moving average is $58.76. The company has a quick ratio of 0.77, a current ratio of 1.60 and a debt-to-equity ratio of 1.15.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 EPS for the quarter, beating analysts' consensus estimates of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. Analysts expect that Bruker Co. will post 2.69 earnings per share for the current fiscal year.

Bruker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be paid a $0.05 dividend. The ex-dividend date is Monday, March 17th. This represents a $0.20 dividend on an annualized basis and a yield of 0.44%. Bruker's payout ratio is 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Co. (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.